Literature DB >> 11813154

Head and neck brachytherapy.

Jean-Jacques Mazeron1, Georges Noël, Jean-Marc Simon.   

Abstract

Experience accumulated over several decades in the treatment of head and neck tumors by irradiation has demonstrated the need for a high tumor dose to achieve local control. With external beam irradiation alone, it is difficult to spare adjacent normal tissues, resulting in undesirable late effects on the salivary glands, mandible, and muscles of mastication. Interstitial implantation is ideally suited to deliver a high dose limited to the volume of the primary tumor, thus maximizing tumor control while minimizing complications. A large experience has been accumulated with low dose rate (LDR) brachytherapy in treatment of carcinoma of oral cavity, oropharynx, and nasopharynx. Recent analysis of large clinical series provided data indicating that modalities of LDR brachytherapy should be optimized in treating these tumors for increasing therapeutic ratio. LDR brachytherapy is now challenged by high dose rate (HDR) brachytherapy and pulsed dose rate (PDR) brachytherapy. Preliminary results obtained with these 2 last modalities will be discussed. Copyright 2002 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2002        PMID: 11813154     DOI: 10.1053/srao.2002.28668

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  14 in total

1.  [Brachytherapy for the treatment of head and neck cancer].

Authors:  J E Meyer; C Brocks; S Maune; V Strnad; J A Werner; B Wollenberg; G Kovács
Journal:  HNO       Date:  2010-09       Impact factor: 1.284

2.  Feasibility of (125)I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma.

Authors:  Chuanxing Li; Fujun Zhang; Weidong Zhang; Liang Zhang; Zilin Huang; Peihong Wu
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-21       Impact factor: 4.553

3.  Interstitial permanent implantation of 125I seeds as salvage therapy for re-recurrent rectal carcinoma.

Authors:  Jun Jie Wang; Hui Shu Yuan; Jin Na Li; Wei Juan Jiang; Yu Liang Jiang; Su Qing Tian
Journal:  Int J Colorectal Dis       Date:  2008-12-16       Impact factor: 2.571

4.  CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy.

Authors:  Jun Jie Wang; Hui Shu Yuan; Jin Na Li; Yu Liang Jiang; Su Qing Tian; Rui Jie Yang
Journal:  Med Oncol       Date:  2009-05-05       Impact factor: 3.064

5.  Modelling the influence of treatment time on the biological effectiveness of single radiosurgery treatments: derivation of "protective" dose modification factors.

Authors:  Bleddyn Jones; John W Hopewell
Journal:  Br J Radiol       Date:  2018-08-21       Impact factor: 3.039

6.  Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy.

Authors:  Antonio Cassio Assis Pellizzon; João Victor Salvajoli; Luiz Paulo Kowalski; Andre Lopes Carvalho
Journal:  Radiat Oncol       Date:  2006-08-08       Impact factor: 3.481

Review 7.  Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.

Authors:  György Kovács
Journal:  J Contemp Brachytherapy       Date:  2014-12-31

Review 8.  Oral cancer: Current role of radiotherapy and chemotherapy.

Authors:  Shao-Hui Huang; Brian O'Sullivan
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-03-01

9.  A digital model individual template and CT-guided 125I seed implants for malignant tumors of the head and neck.

Authors:  Ming-Wei Huang; Shu-Ming Liu; Lei Zheng; Yan Shi; Jie Zhang; Yan-Sheng Li; Guang-Yan Yu; Jian-Guo Zhang
Journal:  J Radiat Res       Date:  2012-08-01       Impact factor: 2.724

10.  High-Dose-Rate Interstitial Brachytherapy (Interventional Radiotherapy) for Conjunctival Melanoma with Orbital Extension.

Authors:  Monica Maria Pagliara; Luca Tagliaferri; Gustavo Savino; Bruno Fionda; Andrea D'Aviero; Angela Lanza; Valentina Lancellotta; Giulia Midena; Maria Antonietta Gambacorta; Maria Antonietta Blasi
Journal:  Ocul Oncol Pathol       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.